Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Model of Abemaciclib in Breast Cancer
NCT07490509Phase 4Not yet recruiting
- Sponsor
- CHU de Poitiers
- Start
- Sep 2026
- Primary completion
- Sep 2029
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of abemaciclib in breast cancer, sponsored by CHU de Poitiers. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
abemaciclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07490509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07490509.